5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.94%
Negative revenue growth while UPM.HE stands at 3.19%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-51.13%
Negative gross profit growth while UPM.HE is at 219.48%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1553.85%
Negative EBIT growth while UPM.HE is at 143.13%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1553.85%
Negative operating income growth while UPM.HE is at 143.13%. Joel Greenblatt would press for urgent turnaround measures.
-533.33%
Negative net income growth while UPM.HE stands at 193.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-472.73%
Negative EPS growth while UPM.HE is at 190.48%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-472.73%
Negative diluted EPS growth while UPM.HE is at 190.48%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
10.58%
Slight or no buybacks while UPM.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
10.58%
Diluted share count expanding well above UPM.HE's 0.02%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-27.78%
Negative OCF growth while UPM.HE is at 8.77%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-1800.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-17.46%
Negative 10Y revenue/share CAGR while UPM.HE stands at 34.57%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-17.46%
Negative 5Y CAGR while UPM.HE stands at 3.38%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-17.46%
Negative 3Y CAGR while UPM.HE stands at 14.49%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-69.73%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-69.73%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-69.73%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-193.38%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-193.38%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-193.38%
Negative 3Y CAGR while UPM.HE is 135.20%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-23.72%
Negative equity/share CAGR over 10 years while UPM.HE stands at 5.74%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-23.72%
Negative 5Y equity/share growth while UPM.HE is at 2.30%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-23.72%
Negative 3Y equity/share growth while UPM.HE is at 21.04%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.21%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-5.45%
Negative asset growth while UPM.HE invests at 2.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-28.18%
We have a declining book value while UPM.HE shows 3.32%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-4.21%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.